2 Growth Stocks to Buy Hand Over Fist in April
Earnings season, which is fast approaching, is often somewhat volatile for the stock market. Companies that overdeliver or fail to deliver can see their share prices move significantly overnight.
However, long-term investors know that one quarterly report rarely changes the fundamental investment thesis of a corporation. It's nice to have money invested in excellent equities that should perform well no matter what happens in the next few weeks.
Let's consider two growth stocks that fit the bill: Eli Lilly (NYSE: LLY) and (NASDAQ: DXCM).
Source Fool.com
Dexcom Inc. Aktie
119,50 €
-0,28 %
Deutliche Kaufsignale für Dexcom Inc. mit mehreren Buy- und keinen Sell-Einschätzungen.
Mit einem Kursziel von 136 € für Dexcom Inc. könnte eine leichte Steigerung gegenüber dem aktuellen Kurs von 119.5 € erreicht werden.
